Viewing Study NCT00590603


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2025-12-31 @ 4:49 AM
Study NCT ID: NCT00590603
Status: TERMINATED
Last Update Posted: 2014-01-08
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor: Duke University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module